Capital International Investors
LEGN icon

Capital International Investors’s Legend Biotech LEGN Stock Holding History

Capital International Investors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41M Buy
1,420,654
+772,804
+119% +$20.8M 0.01% 373
2026
Q1 		$11.7M Sell
647,850
-293,750
-31% -$5.6M ﹤0.01% 406
2025
Q4 		$20.5M Hold
941,600
– – ﹤0.01% 397
2025
Q3 		$30.7M Sell
941,600
-140,873
-13% -$5.2M 0.01% 378
2025
Q2 		$38.4M Sell
1,082,473
-594,787
-35% -$19.3M 0.01% 351
2025
Q1 		$56.9M Sell
1,677,260
-484,244
-22% -$17.4M 0.01% 321
2024
Q4 		$70.3M Sell
2,161,504
-62,884
-3% -$2.6M 0.01% 316
2024
Q3 		$108M Buy
2,224,388
+61,677
+3% +$3.29M 0.02% 265
2024
Q2 		$95.8M Sell
2,162,711
-18,363
-0.8% -$847K 0.02% 272
2024
Q1 		$122M Buy
2,181,074
+356,387
+20% +$21.5M 0.02% 264
2023
Q4 		$110M Sell
1,824,687
-8,116
-0.4% -$514K 0.02% 273
2023
Q3 		$123M Sell
1,832,803
-29,206
-2% -$2.03M 0.03% 258
2023
Q2 		$129M Sell
1,862,009
-88,675
-5% -$5.79M 0.03% 267
2023
Q1 		$94.1M Sell
1,950,684
-218,790
-10% -$10.7M 0.02% 293
2022
Q4 		$108M Sell
2,169,474
-713,286
-25% -$34.6M 0.03% 275
2022
Q3 		$118M Sell
2,882,760
-161,206
-5% -$7.57M 0.03% 276
2022
Q2 		$167M Buy
3,043,966
+233,229
+8% +$9.85M 0.05% 255
2022
Q1 		$102M Buy
2,810,737
+11,755
+0.4% +$464K 0.02% 307
2021
Q4 		$130M Buy
2,798,982
+113,131
+4% +$5.74M 0.03% 300
2021
Q3 		$136M Hold
2,685,851
– – 0.03% 278
2021
Q2 		$110M Buy
2,685,851
+2,019,833
+303% +$68.6M 0.03% 291
2021
Q1 		$19.3M Sell
666,018
-27,570
-4% -$752K ﹤0.01% 391
2020
Q4 		$19.5M Hold
693,588
– – 0.01% 384
2020
Q3 		$21.4M Hold
693,588
– – 0.01% 366
2020
Q2 		$29.5M Buy
+693,588
New +$27.1M 0.01% 328

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Capital International Investors's LEGN Position: Q2 2026 in Review

Capital International Investors increased its Legend Biotech (LEGN) stake by 119% in Q2 2026, buying an estimated $20.8M and bringing the position to 1,420,654 shares worth $41M. The position accounts for 0.01% of the portfolio, ranked #373.

Capital International Investors first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $167M in Q2 2022. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Capital International Investors held 1,420,654 shares of Legend Biotech worth $41M as of Q2 2026.
  • Capital International Investors bought 772,804 Legend Biotech shares in Q2 2026, an estimated $20.8M.
  • Legend Biotech made up 0.01% of Capital International Investors's portfolio in Q2 2026, its #373 holding.
  • Capital International Investors first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • Capital International Investors's Legend Biotech position peaked at $167M in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.